Bio-Rad
ProfileJobs (228)

Bio-Rad

Suggest Edit
    • Healthcarebiotechclinicsdrug developmentlife sciencesmedical diagnostics
    Bio-Rad develops, manufactures, and markets a broad range of products and solutions for the life science research and clinical diagnostics markets. The Company operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cell biology, and food safety. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls that serve clinical laboratories in the diagnostics market. Its products include reagents, instruments, and software which address specific niches within the in vitro diagnostics (IVD) test market.
    Revenue(FY, 2017)
    $2.2 B
    Market capitalization(2018-10-15)
    $8.3 B
    TypePublic
    HQHercules, US
    Founded1952
    Size (employees)8,150 (est)-1%
    Websitebio-rad.com
    Bio-Rad was founded in 1952 and is headquartered in Hercules, US
    Report incorrect company information

    Viewing summary data as a guest

    Sign up for free to see all data

    Key People/Management at Bio-Rad

    Norman Schwartz

    Norman Schwartz

    Chairman of the Board, President and Chief Executive Officer
    Giovanni Magni

    Giovanni Magni

    EVP, Chief Strategy Officer
    John Goetz

    John Goetz

    EVP, Chief Operating Officer
    Michael Crowley

    Michael Crowley

    EVP, Global Commercial Operations
    John Hertia

    John Hertia

    EVP, President, Clinical Diagnostics Group
    Tim Ernst

    Tim Ernst

    EVP, General Counsel & Secretary
    Show more

    Bio-Rad Office Locations

    Bio-Rad has offices in Caracas, Montevideo, Alcobendas, Randburg and in 54 other locations
    Hercules, US (HQ)
    1000 Alfred Nobel Dr
    Hercules, US
    4000 Alfred Nobel Dr
    Hercules, US
    2000 Alfred Nobel Drive
    Hialeah, US
    Suite D-7 6095 NW 167th St
    Villa Ortúzar, AR
    964 Estomba
    Gladesville, AU
    Level 5 446 Victoria Rd
    Show all (68)
    Report incorrect company information

    Bio-Rad Financials and Metrics

    Bio-Rad Revenue

    Bio-Rad's revenue was reported to be $2.16 b in FY, 2017 which is a 4.4% increase from the previous period.
    USD

    Revenue (Q2, 2018)

    		1.1b

    Gross profit (Q2, 2018)

    		603.9m

    Gross profit margin (Q2, 2018), %

    		53.6%

    Market capitalization (15-Oct-2018)

    		8.3b

    Closing stock price (15-Oct-2018)

    		277.8

    Cash (30-Jun-2018)

    		403.0m
    Bio-Rad's current market capitalization is $8.3 b.
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Revenue

    		2.1b2.2b2.0b2.1b2.2b

    Revenue growth, %

    		2%(7%)2%4%

    Cost of goods sold

    		897.8m930.1m972.8m

    Gross profit

    		1.1b1.1b1.2b
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

    Revenue

    		505.1m509.3m536.8m530.6m472.8m506.1m470.0m471.2m516.8m508.7m500.1m504.7m551.5m1.1b

    Cost of goods sold

    		220.9m234.1m239.6m242.1m202.7m226.5m206.5m207.2m236.5m229.3m230.1m231.4m249.3m523.6m

    Gross profit

    		284.2m275.3m297.2m288.6m270.1m279.6m263.5m264.0m280.2m279.5m270.0m273.3m302.2m603.9m

    Gross profit Margin, %

    		56%54%55%54%57%55%56%56%54%55%54%54%55%54%
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Cash

    		331.6m413.3m457.5m456.3m383.8m

    Accounts Receivable

    		372.3m464.8m

    Prepaid Expenses

    		91.0m146.1m

    Inventories

    		525.0m594.8m
    Quarterly
    USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018Q2, 2018

    Cash

    		291.8m364.5m384.7m424.6m425.7m450.1m507.3m403.6m418.7m417.9m291.7m321.6m407.3m403.0m

    Accounts Receivable

    		383.5m383.9m378.9m354.4m342.2m354.2m341.5m381.1m366.3m367.7m373.4m392.8m430.4m404.1m

    Inventories

    		523.5m513.9m520.6m516.0m478.4m501.0m512.7m533.3m541.5m556.4m559.8m580.6m612.2m591.4m

    Current Assets

    		1.7b1.8b1.8b1.8b1.7b1.7b1.8b1.8b1.8b1.9b1.7b1.8b2.0b2.0b
    show all
    Annual
    USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

    Net Income

    		77.8m88.8m113.1m

    Inventories

    Accounts Payable

    Cash From Operating Activities

    		175.5m273.3m186.2m216.4m103.9m
    Quarterly
    USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q1, 2018Q2, 2018

    Net Income

    		31.6m11.5m17.8m28.4m17.4m12.3m30.3m48.7m12.4m

    Accounts Payable

    		125.5m126.6m

    Cash From Operating Activities

    		40.3m118.2m

    Cash From Investing Activities

    		(18.8m)(102.7m)
    show all
    USDY, 2018

    Financial Leverage

    		1.4 x
    Show all financial metrics

    Bio-Rad Revenue Breakdown

    Embed Graph

    Bio-Rad revenue breakdown by business segment: 36.3% from Life Science, 63.0% from Clinical Diagnostics and 0.7% from Other

    Bio-Rad revenue breakdown by geographic segment: 6.5% from Other (primarily Canada and Latin America), 37.0% from United States, 21.4% from Pacific Rim and 35.1% from Europe

    Report incorrect company information

    Competitors

    Agilent Technologies
    Healthcare - Public
    Mettler-Toledo
    Manufacturing & Industrial - Public
    Danaher
    Healthcare - Public
    Roche
    Healthcare - Public
    Becton Dickinson
    Healthcare - Public
    Bruker Corporation
    Healthcare - Public
    Compare competitors

    Bio-Rad Online and Social Media Presence

    Embed Graph
    Report incorrect company information

    Bio-Rad Company Life and Culture

    Report incorrect company information
    Download PDF